Lundbeck
HLUN-B.CO
#2469
Rank
โ‚น506.49 B
Marketcap
โ‚น530.07
Share price
1.94%
Change (1 day)
24.33%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Earnings for Lundbeck (HLUN-B.CO)

Earnings in 2024 (TTM): โ‚น38.66 Billion

According to Lundbeck 's latest financial reports the company's current earnings are โ‚น3.14 Billion. In 2023 the company made an earning of โ‚น38.20 Billion, an increase over its 2022 earnings that were of โ‚น31.39 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lundbeck from 2009 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) โ‚น38.66 B1.19%
2023 โ‚น38.20 B21.69%
2022 โ‚น31.39 B31.79%
2021 โ‚น23.82 B-4.53%
2020 โ‚น24.95 B-45.08%
2019 โ‚น45.43 B-33.97%
2018 โ‚น68.80 B12.76%
2017 โ‚น61.01 B94.32%
2016 โ‚น31.40 B-136.98%
2015 -โ‚น84.93 Billion-1258.1%
2014 โ‚น7.33 B-72.43%
2013 โ‚น26.59 B4.31%
2012 โ‚น25.49 B-55.26%
2011 โ‚น56.99 B6.64%
2010 โ‚น53.44 B-6.68%
2009 โ‚น57.26 B